Coronavirus Update

Smiths Group Plc - Q1 Trading Statement

This content has been sourced from:

Smiths Group Q1

Trading Statement

Smiths Group plc ("Smiths" or "the Group") today announces its trading statement for the first quarter of FY2021. 

Smiths delivered a good trading performance in the first quarter. In a period of ongoing global disruption, the Group continues to demonstrate its resilience, founded on market-leading positions and a high proportion of aftermarket revenues.

Revenue for the three months ended 31 October for Continuing Operations1 was down (2)% on an underlying2 basis. This underpins the Group's confidence in meeting market expectations for the full year.

  • John Crane performed as expected, with challenging market conditions in Energy, partially offset by modest growth in Industrials
  • Smiths Detection delivered a strong performance in Aviation during the quarter, driven by delivery of original equipment orders, which was offset by Other Security Systems
  • Flex-Tek delivered strong Industrial sales that more than offset Aerospace weakness
  • Good momentum continued in Smiths Interconnect

Revenue for the three months ended 31 October for Smiths Medical1 was up 4% on an underlying2 basis driven by further growth in Infusion Systems and Vital Care.

The Group's strategic restructuring programme is progressing well and will deliver the anticipated £30m of savings in the current year and the full £70m benefit in FY2022.

The Group continues to demonstrate its strong cash generation and cash balances at 31 October had increased to £413m.

On 27 October 2020, the Trustee of the Smiths Industries Pension Scheme secured a further £146.5m bulk annuity buy-in agreement with Canada Life, which insured the benefits of a further c.1,000 pensioners, demonstrating further progress in the de-risking of the Company's pension liabilities.